Tenax Therapeutics (TENX) Non-cash Items (2023 - 2026)

Tenax Therapeutics' Non-cash Items history runs 4 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 164685.44% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 164685.44% YoY), while the FY2025 annual figure was $3.1 million, up 299.2% from the prior year.
• Non-cash Items came in at $3.1 million for Q1 2026 at Tenax Therapeutics, down from $41.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $41.4 million in Q4 2025 to a low of -$5.2 million in Q1 2024.
• A 4-year average of $4.8 million and a median of $1332.0 in 2025 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items slumped 199.48% in 2024 and soared 164685.44% in 2026, its largest moves.
• Tenax Therapeutics' Non-cash Items stood at -$1.7 million in 2023, then surged by 145.39% to $783000.0 in 2024, then soared by 5185.06% to $41.4 million in 2025, then tumbled by 92.4% to $3.1 million in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $3.1 million, $41.4 million, and $755.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison